Promising results from new drug combination in patients with
In a presentation at the 28th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics in Munich, Germany, today (Thursday) Dr Takekazu Aoyama, a surgeon and vice president of clinical development at Taiho Oncology Inc, Princeton, USA, described how TAS-114 in combination with another chemotherapy caused tumours to shrink in patients with advanced non-small cell lung cancer, pancreatic cancer, colorectal cancer and breast cancer. In addition, some patients whose cancer had failed to respond to other therapies were able to continue with the treatment and their disease remained stable without progressing for more than six months....

http://medicalxpress.com/news/2016-11-results-drug-combination-patients-advanced.html
Like
Comment
Share